Advertisement
Epilepsy and Behavior
Advanced searchSave search

Masthead

Articles in Press

View All

Issue Highlights

About

Epilepsy & Behavior

Cover Image - Epilepsy & Behavior, Volume 140, Issue
Epilepsy & Behavior is the fastest-growing international journal uniquely devoted to the rapid dissemination of the most current information available on the behavioral aspects of seizures and epilepsy.

Epilepsy & Behavior presents original peer-reviewed articles based on laboratory and clinical research. Topics are drawn from a variety of fields, including clinical neurology, neurosurgery, neuropsychiatry, neuropsychology, neurophysiology, neuropharmacology, and neuroimaging.

Epilepsy & Behavior publishes papers on the study of:

• Localization of ictal and postictal behaviors
• Neuroendocrine aspects of epilepsy
• Psychiatric and psychosocial aspects of epilepsy
• Behavioral aspects of epilepsy surgery
• Cognitive and affective effects of seizure treatment
• Functional imaging
• Animal models

Letters to the Editor will only be considered if they comment on articles that were previously published in Epilepsy & Behavior. The journal does not publish Case Reports. Authors who submit these to Epilepsy & Behavior will be offered a transfer or asked to resubmit their Case Reports to the journal?s companion title, Epilepsy & Behavior Reports.



Cited in MEDLINE/PubMed and Index Medicus, Current Contents/Clinical Medicine, Science Citation Index-Expanded, NeuroScience Citation Index, PsychINFO, and EMBASE.

Companion Journal

Epilepsy & Behavior Reports Epilepsy & Behavior Reports (EBR) is the sister journal to Epilepsy & Behavior. This is an online-only, gold Open Access journal devoted to the rapid publication of case reports on the behavioral aspects of seizures and epilepsy.

EBR places special emphasis on articles that: (1) Provide guidance to clinicians on best practices and clinical research for epilepsy management; (2) Report cutting-edge mutli-disciplinary science related to seizures and epilepsy (Basic and Translational Science); (3) Educate readers about relevant and practical clinical outcomes (Outcome Research); (4) Cite important observations that significantly add to previously-reported novel observations, or provide compelling illustrations of important clinical principles related to the care of patients (Case Reports); and (4) Summarize or editorialize the current state of the literature (Reviews, Commentaries, and Editorials).

Click here to access the content.

Transformative Journal

Epilepsy & Behavior is a transformative journal.

Learn more about APCs and our commitment to OA.

Metrics

Metrics

##
Impact Factor
##
5-Year Impact Factor
##
Eigenfactor Score

Abstract

Despite the availability of 28 antiseizure medications (ASMs), one-third of people with epilepsy fail to achieve sustained freedom from seizures. Clinical outcome is even poorer for children with developmental and epileptic encephalopathies (DEEs), many of which are due to single-gene mutations. Discovery of causative genes, however, has paved the way to understanding the molecular mechanism underlying these epilepsies, and to the rational application, or development, of precision treatments aimed at correcting the specific functional defects or their consequences.

New Editor-in-Chief

February 18th, 2022

We would like to congratulate Professor Marco Mula taking up the role of Editor-in-Chief of Epilepsy & Behavior. Marco has taken over from Professor Schachter who is the Founding Editor of the Journal. We would like to thank Professor Schachter for his vision, dedication and leadership over the last two decades of service as Editor-in-Chief.

Call for Papers

Epilepsy & Behavior currently has a call for papers for a special issue: On Epilepsy and Education. A Global Perspective. Guest Editors are Zeina Chemali and Rani Sarkis.

This special issue will focus on the importance of education in understanding epilepsy in academia, public health and in businesses to decrease global stigma and promote a healthy living for people of all ages suffering from epilepsy. Authors of editorials, opinion pieces, reviews, case reports, and research articles will place this work into a broader international context highlighting differences of culture and community living.

The goal of the SI is to provide an overview of what we know in epilepsy education, worldwide programs and endeavors, successes and pitfalls, challenges, and opportunities to recognizing epilepsy, the stigma around it, the impact on people quality of life, the needed changes in curricula and policies to accommodate a better living for people living with epilepsy (PWE).

Diverse worldwide initiatives will be prioritized over endeavors practiced in North America unless the studies are of a comparative nature. For further details see the link for the special issue.

New Covid-19 Collection

Epilepsy & Behavior has a new COVID-19: Epilepsy & Behavior Online Collection curated by Editor-in-Chief Professor Schachter.

Special Issue on Cannabinoids and Epilepsy

Epilepsy & Behavior produced a special issue that presents an in-depth assessment of the potential of cannabinoids for the effective treatment of epilepsy. Cannabinoids are components of the cannabis plant.

This special issue provides an overview for general neurologists and epileptologists, including historical aspects of cannabis use for epilepsy, overview of cannabis botany, general aspects of the endocannabinoid system as it pertains to epilepsy, pharmacology of cannabinoids, available anecdotal and clinical trial data of cannabinoid use for the treatment of epilepsy, safety data, discussion of possible effects of cannabinoids on the brain including neuroimaging data, and the legal aspects of cannabis production, distribution, and use for the treatment of epilepsy.

The special issue was guest edited by Dr. Jerzy Szaflarski, Director of the Epilepsy Center, University of Alabama at Birmingham, and Dr, Orrin Devinsky, Director, Epilepsy Center, New York University Langone Medical Center, New York.

Most Read (Last 30 Days)

Most Cited (Previous 3 Years)

Advertisement

The content on this site is intended for healthcare professionals.


We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


RELX